{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:05:13Z","timestamp":1769645113073,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["No.2024YFC3406700, 2024YFC3406701"],"award-info":[{"award-number":["No.2024YFC3406700, 2024YFC3406701"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04592-9","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T06:33:47Z","timestamp":1766730827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and safety of Risdiplam for types 1\u20133 spinal muscular atrophy in a single center"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaomei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuizhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"2","key":"4592_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2015","unstructured":"Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51(2):157\u201367.","journal-title":"Muscle Nerve"},{"key":"4592_CR2","doi-asserted-by":"crossref","unstructured":"Finkel R, Bertini E, Muntoni F et al. 209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7\u20139 November 2014, Heemskerk, The Netherlands. Neuromuscular disorders: NMD. 2015;25(7):593\u2013602.","DOI":"10.1016\/j.nmd.2015.04.009"},{"issue":"3","key":"4592_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000;15(3):228\u201337.","journal-title":"Hum Mutat"},{"issue":"1","key":"4592_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >\u200972,400 specimens. Eur J Hum Genetics: EJHG. 2012;20(1):27\u201332.","journal-title":"Eur J Hum Genetics: EJHG"},{"issue":"1","key":"4592_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155\u201365.","journal-title":"Cell"},{"issue":"8","key":"4592_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes AH, Beattie CE. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci. 2009;10(8):597\u2013609.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"4592_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/0883073811420152","volume":"27","author":"X Ge","year":"2012","unstructured":"Ge X, Bai J, Lu Y, et al. The natural history of infant spinal muscular atrophy in china: a study of 237 patients. J Child Neurol. 2012;27(4):471\u20137.","journal-title":"J Child Neurol"},{"issue":"1","key":"4592_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2011.09.001","volume":"46","author":"JA Markowitz","year":"2012","unstructured":"Markowitz JA, Singh P, Darras BT. Spinal muscular atrophy: a clinical and research update. Pediatr Neurol. 2012;46(1):1\u201312.","journal-title":"Pediatr Neurol"},{"issue":"10","key":"4592_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJMoa2009965","volume":"384","author":"G Baranello","year":"2021","unstructured":"Baranello G, Darras BT, Day JW, et al. Risdiplam in type 1 spinal muscular atrophy. N Engl J Med. 2021;384(10):915\u201323.","journal-title":"N Engl J Med"},{"issue":"6","key":"4592_CR10","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/cpt.2247","volume":"110","author":"G Baranello","year":"2021","unstructured":"Baranello G, Gorni K, Daigl M, et al. Prognostic factors and Treatment-Effect modifiers in spinal muscular atrophy. Clin Pharmacol Ther. 2021;110(6):1435\u201354.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"4592_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","volume":"20","author":"AM Glanzman","year":"2010","unstructured":"Glanzman AM, Mazzone E, Main M, et al. The children\u2019s hospital of Philadelphia infant test of neuromuscular disorders (CHOP INTEND): test development and reliability. Neuromuscul Disorders: NMD. 2010;20(3):155\u201361.","journal-title":"Neuromuscul Disorders: NMD"},{"issue":"1","key":"4592_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12883-017-0790-9","volume":"17","author":"MC Pera","year":"2017","unstructured":"Pera MC, Coratti G, Forcina N, et al. Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy. BMC Neurol. 2017;17(1):39.","journal-title":"BMC Neurol"},{"issue":"1","key":"4592_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1067\/mpd.2002.119626","volume":"140","author":"MF Frisone","year":"2002","unstructured":"Frisone MF, Mercuri E, Laroche S, et al. Prognostic value of the neurologic optimality score at 9 and 18 months in preterm infants born before 31 weeks\u2019 gestation. J Pediatr. 2002;140(1):57\u201360.","journal-title":"J Pediatr"},{"key":"4592_CR14","first-page":"86","volume":"450","author":"WHO Motor Development Study","year":"2006","unstructured":"WHO Motor Development Study. : windows of achievement for six gross motor development milestones. Acta Paediatr (Oslo Norway: 1992) Supplement. 2006;450:86\u201395.","journal-title":"Acta Paediatr (Oslo Norway: 1992) Supplement"},{"issue":"18","key":"4592_CR15","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus Sham control in Infantile-Onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723\u201332.","journal-title":"N Engl J Med"},{"issue":"12","key":"4592_CR16","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/S1474-4422(22)00339-8","volume":"21","author":"R Masson","year":"2022","unstructured":"Masson R, Mazurkiewicz-Be\u0142dzi\u0144ska M, Rose K, et al. Safety and efficacy of Risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial. Lancet Neurol. 2022;21(12):1110\u20139.","journal-title":"Lancet Neurol"},{"issue":"8","key":"4592_CR17","doi-asserted-by":"publisher","first-page":"e16309","DOI":"10.1111\/ene.16309","volume":"31","author":"G Coratti","year":"2024","unstructured":"Coratti G, Bovis F, Pera MC, et al. Determining minimal clinically important differences in the Hammersmith functional motor scale expanded for untreated spinal muscular atrophy patients: an international study. Eur J Neurol. 2024;31(8):e16309.","journal-title":"Eur J Neurol"},{"issue":"4","key":"4592_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/1740774516643498","volume":"13","author":"S Huang","year":"2016","unstructured":"Huang S, Fiero MH, Bell ML. Generalized estimating equations in cluster randomized trials with a small number of clusters: review of practice and simulation study. Clin Trials. 2016;13(4):445\u20139.","journal-title":"Clin Trials"},{"issue":"21","key":"4592_CR19","doi-asserted-by":"publisher","first-page":"e2103","DOI":"10.1212\/WNL.0000000000207878","volume":"101","author":"V Aponte Ribero","year":"2023","unstructured":"Aponte Ribero V, Mart\u00ed Y, Batson S, et al. Systematic literature review of the natural history of spinal muscular atrophy: motor Function, Scoliosis, and contractures. Neurology. 2023;101(21):e2103\u201313.","journal-title":"Neurology"},{"issue":"6","key":"4592_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/ana.25101","volume":"82","author":"SJ Kolb","year":"2017","unstructured":"Kolb SJ, Coffey CS, Yankey JW, et al. Natural history of infantile-onset spinal muscular atrophy. Ann Neurol. 2017;82(6):883\u201391.","journal-title":"Ann Neurol"},{"issue":"1","key":"4592_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/phar.2866","volume":"44","author":"C Pascual-Morena","year":"2024","unstructured":"Pascual-Morena C, Mart\u00ednez-Vizca\u00edno V, Cavero-Redondo I, et al. Efficacy of Risdiplam in spinal muscular atrophy: A systematic review and meta-analysis. Pharmacotherapy. 2024;44(1):97\u2013105.","journal-title":"Pharmacotherapy"},{"issue":"12","key":"4592_CR22","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s12519-024-00846-7","volume":"20","author":"C Chen","year":"2024","unstructured":"Chen C, Zhang C, Wu DW, et al. Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience. World J Pediatr. 2024;20(12):1270\u201382.","journal-title":"World J Pediatr"},{"issue":"7","key":"4592_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, et al. Nusinersen versus Sham control in Later-Onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625\u201335.","journal-title":"N Engl J Med"},{"issue":"2","key":"4592_CR24","first-page":"93","volume":"19","author":"F Liu","year":"2024","unstructured":"Liu F, Wang J, Guo X, et al. A case series report of One-Year Follow-Up on Risdiplam monotherapy for children with spinal muscular atrophy. Chin J Evidence-Based Pediatr. 2024;19(2):93\u20137.","journal-title":"Chin J Evidence-Based Pediatr"},{"issue":"3","key":"4592_CR25","doi-asserted-by":"publisher","first-page":"e0298609","DOI":"10.1371\/journal.pone.0298609","volume":"19","author":"L Yu","year":"2024","unstructured":"Yu L, Liu L. Exploration of adverse events associated with Risdiplam use: retrospective cases from the US food and drug administration adverse event reporting system (FAERS) database. PLoS ONE. 2024;19(3):e0298609.","journal-title":"PLoS ONE"},{"issue":"12","key":"4592_CR26","doi-asserted-by":"publisher","first-page":"e173702","DOI":"10.1172\/JCI173702","volume":"134","author":"DM Leow","year":"2024","unstructured":"Leow DM, Ng YK, Wang LC, et al. Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy. J Clin Invest. 2024;134(12):e173702.","journal-title":"J Clin Invest"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04592-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04592-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04592-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:45:52Z","timestamp":1769600752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04592-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4592"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04592-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of the Children\u2019s Hospital of Fudan University (No: (2021)307). The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent to participate in this study was provided by the participants\u2019 legal guardian. No potentially identifiable human images or data is presented in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}